Literature DB >> 15013123

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

Joseph E Rahman1, Emelie F Helou, Ramona Gelzer-Bell, Richard E Thompson, Chih Kuo, E Rene Rodriguez, Joshua M Hare, Kenneth L Baughman, Edward K Kasper.   

Abstract

OBJECTIVES: This study analyzed the utility of electrocardiographic (ECG) and echocardiographic findings in the diagnosis of amyloidosis proven by endomyocardial biopsy.
BACKGROUND: Cardiac amyloidosis is associated with characteristic ECG and echocardiographic changes, yet each finding alone is relatively nonspecific. A combination of noninvasive prognostic parameters would be desirable for this tissue-based diagnosis.
METHODS: We performed an analysis of 196 consecutive patients referred for endomyocardial biopsy because of clinical suspicion of cardiac amyloidosis. The diagnosis was confirmed in 58 patients (29%). The ECGs, echocardiograms, and right heart hemodynamic data were reviewed to determine which findings strongly correlate with the diagnosis. These findings were then used to build multivariate logistic regression models that predict the log-odds of having cardiac amyloidosis.
RESULTS: The univariate analysis showed that low-voltage and pseudo-infarction patterns on the ECG and increased myocardial thickness and speckled-appearing myocardium on the echocardiogram were associated with biopsy-proven cardiac amyloidosis (each p < 0.01). In multivariate logistic regression models, a combination of a low voltage and measures of myocardial thickness produced the most statistically useful models. For instance, one model showed that if a low voltage was present and interventricular septal thickness is >1.98 cm, the diagnosis of cardiac amyloidosis could be made with a sensitivity of 72% and a specificity of 91%. In this model, the positive predictive and negative predictive values were 79% and 88%, respectively.
CONCLUSIONS: In patients with suspected cardiac amyloidosis, a combination of noninvasive parameters-namely, a low voltage and increased intraventricular septal thickness-is a useful diagnostic tool.

Entities:  

Mesh:

Year:  2004        PMID: 15013123     DOI: 10.1016/j.jacc.2003.08.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  77 in total

1.  Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography.

Authors:  Jing Wang; Xiangquan Kong; Haibo Xu; Guofeng Zhou; Dandan Chang; Dingxi Liu; Li Zhang; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Authors:  Roberta Mussinelli; Francesco Salinaro; Alessio Alogna; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

Review 3.  Transthyretin-related amyloidoses and the heart: a clinical overview.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Letizia Riva; Simone Longhi; Ilaria Gallelli; Massimiliano Lorenzini; Paolo Ciliberti; Elena Biagini; Fabrizio Salvi; Angelo Branzi
Journal:  Nat Rev Cardiol       Date:  2010-05-18       Impact factor: 32.419

Review 4.  Cardiac and pericardial abnormalities on chest computed tomography: what can we see?

Authors:  J Bogaert; M Centonze; R Vanneste; M Francone
Journal:  Radiol Med       Date:  2010-01-07       Impact factor: 3.469

Review 5.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

Review 6.  Role of echocardiography in cancer care.

Authors:  J K Raikhelkar; R M Steingart; C L Chen
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

7.  Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Authors:  F Aus dem Siepen; R Bauer; A Voss; S Hein; M Aurich; J Riffel; D Mereles; C Röcken; S J Buss; H A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2017-09-27       Impact factor: 5.460

8.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

9.  The findings of electrocardiography in patients with cardiac amyloidosis.

Authors:  Zhongwei Cheng; Kongbo Zhu; Zhuang Tian; Dachun Zhao; Quancai Cui; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

10.  Nephrotic syndrome: A twist in the tail.

Authors:  Vinay Sakhuja; Vivekanand Jha; Amanjit Bal
Journal:  Indian J Nephrol       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.